Comprehensive genomic profiling from
a blood sample. Fast.
For patients with advanced solid tumour cancers
Before 1st Line Treatment
Get ahead of the challenges of tissue testing in advanced NSCLC by utilizing Guardant360 to guide 1st line treatment decisions
Get genomic information on over 70+ genes, including MSI across multiple solid tumors to help find cancer therapies and clinical trials.